Literature DB >> 823633

Evidence that D-penicillamine alters the course of rheumatoid arthritis.

T Gibson, E C Huskisson, J A Wojtulewski, P J Scott, H W Balme, H C Burry, R Grahame, F D Hart.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 823633     DOI: 10.1093/rheumatology/15.3.211

Source DB:  PubMed          Journal:  Rheumatol Rehabil        ISSN: 0300-3396


× No keyword cloud information.
  11 in total

1.  Severe hypophosphataemia in a patient with Paget's disease of bone: paraneoplastic osteomalacia?

Authors:  M D'Amore; F Coluccia; F P Cantatore; M Carrozzo
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

2.  Radiological evaluation of erosions: a quantitative method for assessing long-term remittive therapy in rheumatoid arthritis.

Authors:  W M O'Brien
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

Review 3.  Joint damage in rheumatoid arthritis: radiological assessments and the effects of anti-rheumatic drugs.

Authors:  D L Scott; P A Bacon
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

Review 4.  Assessing the progression of joint damage in rheumatoid arthritis.

Authors:  D L Scott; M Farr
Journal:  Drugs       Date:  1986       Impact factor: 9.546

5.  The effects of auranofin and parenteral gold in the treatment of rheumatoid arthritis: an X-ray analysis.

Authors:  A Larsen; J Horton; C Howland
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

Review 6.  Rational use of disease-modifying antirheumatic drugs.

Authors:  D E Furst
Journal:  Drugs       Date:  1990-01       Impact factor: 9.546

7.  Does second-line therapy affect the radiological progression of rheumatoid arthritis?

Authors:  T Pullar; J A Hunter; H A Capell
Journal:  Ann Rheum Dis       Date:  1984-02       Impact factor: 19.103

8.  Progressive joint damage during penicillamine therapy for rheumatoid arthritis.

Authors:  D L Scott; A Greenwood; R Bryans; E C Huskisson
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

9.  Discriminatory indices of response of patients with rheumatoid arthritis treated with D-penicillamine.

Authors:  J S Dixon; M E Pickup; J R Lowe; C Hallett; M R Lee; V Wright
Journal:  Ann Rheum Dis       Date:  1980-08       Impact factor: 19.103

10.  Second line therapy in rheumatoid arthritis--a four year prospective study.

Authors:  T Pullar; J A Hunter; H A Capell
Journal:  Clin Rheumatol       Date:  1985-06       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.